Male Reproductive Cancers Resource Center

Viewpoints

Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity

Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity

Acute peripheral neuropathy often does not resolve between cycles of treatment and severity often increases between cycles.

PRO-CTCAE Provides "Missing Patient Voice" in Reporting Cancer Treatment Symptoms

PRO-CTCAE Provides "Missing Patient Voice" in Reporting Cancer Treatment Symptoms

A prescription drug's label AE section is almost entirely based on clinicians' impression of patients' symptoms, not the patients' own reports.

Feature Articles

Molecular Profiles Can be Used for Early Detection for Aggressive Prostate Cancer

Molecular Profiles Can be Used for Early Detection for Aggressive Prostate Cancer

A tool has been developed that can help clinicians identify the most aggressive prostate cancers.

Male Reproductive Cancers Resources

More Male Reproductive Cancers Resources

Managing Bone Health in Prostate Cancer

This fact sheet answers some common questions about prostate cancer, bone scan, and metastasis.

Prostate Cancer: What to Know About Screening, Diagnosis

This fact sheet reviews current prostate cancer screening tests, guidelines, PSA, and risk factors.

Testicular Cancer Fact Sheet

This fact sheet provides information on symptoms, pain, causes, and treatments for testicular, testicle cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs